Exploring Survival Outcomes in Metastatic Colorectal Cancer Harboring KRAS A146 Mutations: Important Distinction or Simple Distraction?
JCO Precis Oncol
.
2022 Mar:6:e2100564.
doi: 10.1200/PO.21.00564.
Authors
Richard Pham
1
,
Azim Jalali
1
,
Chia Chong
1
,
Vanessa Wong
1
,
Kate Dunn
1
,
Peter Gibbs
1
Affiliation
1
Richard Pham, MBBS, Epworth Healthcare, Melbourne, Australia WEHI, Melbourne, Australia and Azim Jalali, MBBS, Chia Chong, MBBS, Vanessa Wong, MBBS, Kate Dunn, MBBS, and Peter Gibbs, MBBS, Personalised Oncology Division, WEHI.
PMID:
35344448
DOI:
10.1200/PO.21.00564
No abstract available
Publication types
Letter
Comment
MeSH terms
Colonic Neoplasms*
Humans
Mutation
Proto-Oncogene Proteins p21(ras)* / genetics
ras Proteins / genetics
Substances
KRAS protein, human
Proto-Oncogene Proteins p21(ras)
ras Proteins